NCT05838066
- Conditions
- Breast Diseases, Breast Neoplasms, First-line Treatment of HER2-positive Recurrent or Metastatic Breast Cancer, +4 more
- Locations
-
- Clinical Trials Information Group Beijing, chaoyang, China
Clinical trial condition
Explore clinical trials studying Skin Diseases. Study availability and eligibility vary by location and protocol.
NCT05838066
NCT06722534
NCT04824027
NCT06993636
NCT05867004
NCT01793168
NCT06049355
NCT06991946
NCT06992336
NCT06991790